Exelixis
EXEL
#1855
Rank
NZ$18.48 B
Marketcap
NZ$68.67
Share price
-2.18%
Change (1 day)
15.38%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company